Home > Boards > US Listed > Biotechs > Aerie Pharmaceuticals Inc. (AERI)

Just a few months to go for the

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Johnny_C Member Profile
Member Level 
Followed By 15
Posts 6,213
Boards Moderated 0
Alias Born 04/20/16
160x600 placeholder
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/17/2019 4:38:44 PM
Aerie Pharmaceuticals Announces Appointment of Jeffrey Calabrese, CPA, as Director of Accounting Business Wire - 6/17/2019 6:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/13/2019 6:33:00 AM
Aerie Pharmaceuticals to Present at Two Upcoming Investor Conferences Business Wire - 6/11/2019 7:30:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/4/2019 6:35:55 AM
Aerie Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference Business Wire - 5/28/2019 7:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/24/2019 10:12:26 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:17:56 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:15:55 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:13:05 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:05:30 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:04:24 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/23/2019 6:03:09 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/23/2019 4:26:11 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2019 5:21:41 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2019 5:19:37 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/17/2019 5:18:17 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/14/2019 6:33:31 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/8/2019 6:42:01 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/7/2019 4:23:55 PM
Aerie Pharmaceuticals Reports First Quarter 2019 Financial Results and Provides Business Update Business Wire - 5/7/2019 4:01:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/3/2019 7:44:30 AM
Aerie Pharmaceuticals Announces Additional Undrawn $100M Credit Facility with Deerfield Management, Increasing Availability t... Business Wire - 5/2/2019 6:33:00 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/1/2019 6:50:22 AM
Aerie Pharmaceuticals Announces U.S. Launch of Rocklatan® & Increase in Rhopressa® Medicare Part D Coverage to Approximatel... Business Wire - 5/1/2019 6:30:00 AM
Johnny_C Member Level  Sunday, 11/19/17 10:01:52 AM
Re: None
Post # of 147 
Just a few months to go for the big news. I have been an Aeri supporter for almost 2 years. Bought at 10 sold at 32, rebought at 17 sold at average of 62.

Entered very small at 59.

What is problematic is the lack of deals and mergers being done. They look to have 2 superstar blockbusters and the stock may very well be 80 to 100 if a buyout were to occur.

That is less likely though as they are hiring their own sales force. Not only does that present the problem of salesman having a one trick pony product for now, but they have zero experience running a sales team. Even hiring experienced people from big pharma is not encouraging as they are use to having a portfolio of drugs, established relationships and a huge marketing budget. There is a possibility of the product having a label as well.

This is not a Gilead situation where a drug takes over a market immediately. Most small biotech’s lose money for at least 3 years, and lose a lot of money. Aeri could bled 100’s if millions of dollars before it reaches us profitable, and the over under on pivoting to profits is 3.5 years.

The upside is that Aeri could be a billion dollar drug, or more. We bought Aeri for turnaround and buyout just like rite aid, Salix, Receptos, Sarepta BMY.

Aeri seemed a perfect fit for AGN, but it is not looking like that now. Tax reform doesn’t benefit AGN. Maybe they will get bought out but not optimistic at this point.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist